Categoría: ADHD
Etiquetas: #diagnosis, #technology, news, technological advances
More content you may find interesting
Nesplora, the innovative tool in the field of mental health, has been selected by the UK’s National Institute for Health and Care Excellence (NICE) as a recommendation for the assessment of Attention Deficit Hyperactivity Disorder (ADHD).
This recognition is part of NICE’s Diagnostic Evaluation Program, which is responsible for reviewing new and innovative diagnostic technologies, with the aim of ensuring the best care for individuals.
The validation of Nesplora Attention Kids Aula and Nesplora Attention Aquarium by NICE not only endorses the quality of these tools, but also underlines their potential in the field of ADHD diagnostic research.
This important endorsement positions Nesplora as a leader in the assessment of this disorder, opening up new opportunities for its use in different clinical and educational contexts.
Why this recognition is important:
1.Scientific validation.
Having the backing of a leading authority in the evaluation of health technologies, such as NICE, provides Nesplora with scientific validation that supports its efficacy and reliability in the evaluation of ADHD.
2. Potential for research.
NICE’s recognition underscores Nesplora’s significant potential to contribute to ADHD research, promoting greater understanding and better approaches to its diagnosis and treatment.
3. Boosting innovation:
This milestone represents an incentive for other companies and organizations to continue developing advanced tools that improve diagnosis and treatment in the field of mental health.
In conclusion, NICE’s recognition of Nesplora not only validates its technology, but also marks an important step towards advancing the assessment and treatment of ADHD, benefiting both patients and professionals worldwide.
More info at: